Developing an Outcome-Based Pharmaceutical Science Curriculum: an Evaluation Based on Triangulation Method

Cross-Efficiency Evaluation Based on an Interval Method

Constructing basic science theoretical curriculum evaluation tool, based on Problem-based strategy (A guide for application).

Introduction: A variety of educational strategies appropriate for medical student learning have been introduced. Problem- based learning is a major, complex and widespread strategy in medical education, especially in basic science education. In the SPICES model PBL is presented as continuums (from information oriented learning to problem-based learning). In this study, we developed a questionna...

Health science curriculum reform: Outcome evaluation

Th e Faculty of Health Sciences at the University of Sydney has recently undertaken signifi cant undergraduate curriculum reform aimed at reducing the number of similar, overlapping units of study and increasing the opportunities for disciplinary mingling at an undergraduate level. Th is paper presents some preliminary fi ndings concerning the impact of curriculum change in the context of a sin...

An Evaluation of Integrated Curriculum Based on Students’ Perspective

Purpose: For medical students to have a meaningful learning experience, the curriculum must integrate what students are learning in class with the skills and knowledge required in the clinicalsetting. To satisfy these needs, an integrated curriculum (IC) has been operating at Chonnam National University Medical School since 1999. The purpose of this study was to evaluate the changes in IC stude...

Developing a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies

The supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. Over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. In addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the wa...